2658512
SBDFP · Branded drug packinfluenza A virus A/Brisbane/02/2018 (H1N1) antigen / influenza A virus A/South Australia/34/2019 (H3N2) antigen / influenza B virus B/Phuket/3073/2013 antigen / influenza B virus B/Washington/02/2019 antigen Prefilled Syringe [Fluzone Quadrivalent 2020 Southern Hemisphere]
Concept
Cross-maps
Synonyms
No additional synonyms recorded.
Related concepts
Common questions
What is the RxNorm code for influenza A virus A/Brisbane/02/2018 (H1N1) antigen / influenza A virus A/South Australia/34/2019 (H3N2) antigen / influenza B virus B/Phuket/3073/2013 antigen / influenza B virus B/Washington/02/2019 antigen Prefilled Syringe [Fluzone Quadrivalent 2020 Southern Hemisphere]?
influenza A virus A/Brisbane/02/2018 (H1N1) antigen / influenza A virus A/South Australia/34/2019 (H3N2) antigen / influenza B virus B/Phuket/3073/2013 antigen / influenza B virus B/Washington/02/2019 antigen Prefilled Syringe [Fluzone Quadrivalent 2020 Southern Hemisphere] is coded as 2658512 in RxNorm.
What is RxNorm code 2658512?
2658512 is the RxNorm identifier for influenza A virus A/Brisbane/02/2018 (H1N1) antigen / influenza A virus A/South Australia/34/2019 (H3N2) antigen / influenza B virus B/Phuket/3073/2013 antigen / influenza B virus B/Washington/02/2019 antigen Prefilled Syringe [Fluzone Quadrivalent 2020 Southern Hemisphere]. It is included in the current monthly NLM RxNorm release.
What term type is RxCUI 2658512?
2658512 is a SBDFP (Branded drug pack) in RxNorm.
What is the UMLS mapping for 2658512?
2658512 maps to UMLS C5842363.